惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Google DeepMind News
Google DeepMind News
S
Security Affairs
阮一峰的网络日志
阮一峰的网络日志
L
LangChain Blog
Microsoft Azure Blog
Microsoft Azure Blog
雷峰网
雷峰网
Recent Announcements
Recent Announcements
WordPress大学
WordPress大学
The GitHub Blog
The GitHub Blog
博客园_首页
The Cloudflare Blog
M
MIT News - Artificial intelligence
博客园 - 【当耐特】
MyScale Blog
MyScale Blog
S
SegmentFault 最新的问题
P
Proofpoint News Feed
Y
Y Combinator Blog
Jina AI
Jina AI
博客园 - 聂微东
A
About on SuperTechFans
Blog — PlanetScale
Blog — PlanetScale
博客园 - 司徒正美
G
Google Developers Blog
云风的 BLOG
云风的 BLOG
F
Full Disclosure
CTFtime.org: upcoming CTF events
CTFtime.org: upcoming CTF events
Microsoft Security Blog
Microsoft Security Blog
爱范儿
爱范儿
T
Tailwind CSS Blog
J
Java Code Geeks
Vercel News
Vercel News
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
Stack Overflow Blog
Stack Overflow Blog
罗磊的独立博客
小众软件
小众软件
酷 壳 – CoolShell
酷 壳 – CoolShell
T
The Blog of Author Tim Ferriss
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
博客园 - 三生石上(FineUI控件)
W
WeLiveSecurity
PCI Perspectives
PCI Perspectives
Attack and Defense Labs
Attack and Defense Labs
Exploit-DB.com RSS Feed
Exploit-DB.com RSS Feed
cs.CV updates on arXiv.org
cs.CV updates on arXiv.org
宝玉的分享
宝玉的分享
IT之家
IT之家
Hacker News: Ask HN
Hacker News: Ask HN
The Register - Security
The Register - Security
T
The Exploit Database - CXSecurity.com
T
Threat Research - Cisco Blogs

Fortune | FORTUNE

One man can kill Bill Ackman’s $64 billion bid for Universal Music Group—and no one knows what he’ll do | Fortune Poppi’s cofounder pitched her startup on Shark Tank while 9 months pregnant and landed a $400,000 deal—now it's worth $2 billion | Fortune Teen boys are choosing AI girlfriends over real ones for 'maximum control, zero rejection'—experts say it could make them unemployable | Fortune A United American merger is by no means impossible given the president 'loves big deals' | Fortune Reed Hastings’s planned exit from $455 billion Netflix ‘had nothing to do with’ the failed deal for Warner Bros., says Ted Sarandos | Fortune Meet Joe McCann: The high-flying crypto trader held in Tanzania after sudden death of his influencer fiancée Ashly Robinson | Fortune Gen Z is carving a different path in the housing market by doing it alone | Fortune U.S. Catholic leaders criticize Trump for ‘disparaging words’ about the pope as Vatican clash risks alienating Catholic voters | Fortune China has ‘nearly erased’ America’s lead in AI—and the flow of tech experts moving to the U.S. is slowing to a trickle, Stanford report says | Fortune Self-made millionaire behind $5 billion Skims Emma Grede says it all began with a cold call to Kris Jenner: Emma Grede—the self-made millionaire behind the $5 billion Skims empire—says it all began with an audacious cold call to Kris Jenner: ‘The difference between me and someone else is, I made it happen’ | Fortune Americans have never been this gloomy about the economy. Wall Street has never cashed in harder | Fortune ‘The college grading system [is] almost meaningless’: People see the Ivy League as an easy A and with flawed admissions standards | Fortune The CEO of $8.5 billion Japanese car giant Nissan plays the drums in a band and hits the tennis courts to destress from the top job | Fortune New York governor's take on a millionaires tax: fancy pied-à-terre second apartments worth over $5 million | Fortune Pope Leo XIV: A ‘handful of tyrants’ are ravaging earth with war and exploitation | Fortune Trump has no plan to cut the $39 trillion national debt, but he does want to cut childcare. His budget director is scrambling to clarify | Fortune China's economy grows 5% in first quarter, surprising economists to the upside | Fortune Everyone was wondering what Trump wanted more: Warsh smoothly seated at the Fed, or for Powell to pay. We have our answer | Fortune Palantir exec: the biggest mistake retailers are making with AI? Trying to do it all with one agent | Fortune American YouTuber who calls himself a 'troll' sentenced to 6 months in Korean prison for literally dancing on wartime graves | Fortune BBC plans to cut up to 2,000 jobs to save 10% of annual budget | Fortune Canva debuts a new suite of agentic tools, as the design app quietly becomes one of the world’s most used AI services | Fortune Moody's CEO: AI has a trust problem – better models won’t fix it | Fortune Top New York surgeon: Americans have better data for choosing restaurants than surgeons. That has to change | Fortune The Iran war’s fertilizer shock is hammering American farmers, and 70% can’t afford what they need for this year’s growing season | Fortune Education experts to Mamdani: Why are you foisting AI on our kids? | Fortune This CEO pirated video games as a teen and became a hacker for the Air Force. Now he’s built a $3 billion cyber firm | Fortune Teacher, blame thyself: Yale report savages Ivy League schools for destroying American trust in higher education | Fortune Fed chair nominee Kevin Warsh is worth more than $100 million and has stakes in SpaceX and Polymarket | Fortune From wool sneakers to GPUs: Allbirds’ desperate AI pivot and 600% stock surge, explained | Fortune The Sam Altman attack is putting two anti-AI groups under scrutiny—but the story is more complicated | Fortune Elizabeth Warren on her proposal to bring back IRS Direct File: ‘For just one day of bombing Iran, we could pay for 20 years’ | Fortune ‘I am certain’: Harvard policy expert warns the true cost of the Iran war to U.S. taxpayers will exceed $1 trillion | Fortune The CEO of a $24 billion Dutch lender has sandwiches once a week with the staff to hear their views and get them on side with cost cuts | Fortune Why insurance giant Travelers' CTO is placing fewer, bigger bets on AI | Fortune Current price of oil as of April 15, 2026 | Fortune The dirty secret behind Big Tech’s AI arms race: Massive hardware investments that are obsolete in 3 years | Fortune Dow’s CEO handoff elevates an insider and seasoned operator | Fortune Anthropic faces user backlash over reported performance issues with its Claude AI chatbot | Fortune Stock futures sink while oil spikes as the U.S. Navy looks to squeeze Iran's economy and break its grip on the Strait of Hormuz | Fortune A major U.S. gasoline production hub is in such a severe drought that its refineries may be hobbled. 'We are actively praying for a hurricane' | Fortune U.K. won’t take part in Trump’s planned blockade of Hormuz strait | Fortune Hungarian voters oust Viktor Orbán, a close ally of Trump and Putin, despite late campaign push from JD Vance | Fortune Blazing hot IPOs, an AI agent craze, and a new word for ‘token’: Here’s what’s happening in the world of Chinese AI | Fortune Iran’s crumbling economy is the regime’s greatest weakness with prices up 40% since the war began while authorities worry about making payroll | Fortune Here’s how a U.S. naval blockade of the Strait of Hormuz could work. ‘This is a big task, and it’s a big gamble’ | Fortune Intuit was an AI pioneer. Why its stock became a SaaSpocalypse casualty | Fortune Artemis III will practice docking Orion with lunar landers in Earth orbit next year while Musk’s Starship and Bezos’ Blue Moon compete for Artemis IV | Fortune Oil tankers U-turn in Hormuz as U.S.-Iran talks break down Saudi Arabia says East-West pipeline restored to full capacity In 2011, Barack Obama said it was time to ‘pivot’ to Asia. But 15 years later, the U.S. is still at war in the Middle East Trump says U.S. Navy to impose Hormuz blockade after Iran ceasefire talks end with no deal. ‘No one who pays an illegal toll will have safe passage’ This TikTok sensation sold her startup for $2 billion. Now Pepsi is letting ‘Poppi be Poppi’ ‘Almost unmanageable’: Raising a child in the U.S. now costs more than $300,000 As Iran peace talks fail, Trump and Joe Rogan watch a hobbled fighter triumph in a brutal cage match Haiti stares down starvation as Iran War drives 200,000 into acute food emergency status ‘I just keep seeing a lot of different aspects of life getting more expensive’: New car prices are up 30% over 6 years America is not ready for its own longevity crisis — and 2026 is the wake-up call | Fortune JD Vance leaves Pakistan after marathon talks with Iran end without a deal as Tehran refuses U.S. demand not to develop nuclear weapons | Fortune Average price of new cars nears $50,000 as automakers focus on big pickups and SUVs while cheaper sedans get phased out | Fortune Navy tests Hormuz blockade as expert says U.S. military prepares for round 2 and could degrade Iran’s hold over the strait to a ‘manageable level’ | Fortune Pakistan sends military force to Saudi Arabia as part of pact | Fortune Three oil supertankers sail through the Strait of Hormuz | Fortune Trump downplays talks for ceasefire deal with Iran, claiming military victory. 'It doesn’t matter. From the standpoint of America, we win' | Fortune Boeing’s moon rocket faces uncertain future under Trump’s NASA | Fortune Appeals court says national security implications of halting White House ballroom construction must be weighed | Fortune Some of cheapest fuel can be found on Native American reservations as tribes are exempt from state gas taxes | Fortune JD Vance begins talks with Iran in Pakistan while Trump claims U.S. has begun 'clearing out' the Strait of Hormuz | Fortune 'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuz | Fortune U.S. Navy ships transit Hormuz ahead of mine-clearing mission | Fortune Over a third of Ireland's fuel stations are empty and truck and tractor drivers are protesting nationwide | Fortune Some communities are enduring unprecedented long waits on federal disaster requests, and Democrat-led states say they're being denied | Fortune These niche AI startups are trying to protect the Pentagon’s secrets | Fortune Former Tesla president reveals the ‘single most important thing’ you can do for your career—it’s a habit Elon Musk and Warren Buffett share too | Fortune Ingersoll Rand CEO: here's how employee ownership helped drive more than 8x enterprise value growth | Fortune The petrodollar faces increased risk, but a petroyuan is ‘far-fetched’ as fears of U.S. losing superpower status are overhyped, strategist says | Fortune Palantir CEO says AI ‘will destroy’ humanities jobs, but there will be ‘more than enough jobs’ for people with vocational training | Fortune Warren Buffett says 'accumulating great amounts of money' doesn’t achieve greatness—He still lives in a $31,500 Nebraska home and clipped coupons | Fortune Starbucks' game plan to roll out AI chatbots at cafes could serve as a 'litmus test' for the industry, analyst says | Fortune Data centers and gas demand make boring pipelines great again | Fortune The 'Tuscan Mom' aesthetic is taking over TikTok as Gen Z glamorize McMansions and reject millennial gray | Fortune Man's best friend may soon live a little longer thanks to a new pill promising to extend your pup's lifespan | Fortune Danantara CIO: Indonesia can anchor the AI and energy economy—if governance keeps pace | Fortune OpenAI’s TBPN deal shows how talent, media, and influence are collapsing into one | Fortune AI promises to free workers from grunt work, but psychologists say those mindless tasks are exactly what our brains need to recover | Fortune The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Belt | Fortune 'It’s 13 minutes of things that have to go right': Artemis II splashes down despite faulty heat shield | Fortune Fed seeks details on U.S. banks' exposure to private credit firms | Fortune The Navy confirmed an ‘abundant amount’ of Uncrustables when the Artemis II crew lands. Smucker’s just offered them a lifetime supply | Fortune Meet ‘trendslop,’ the new, AI-fueled scourge of workplace consultants everywhere | Fortune Amazon is still paying Jeff Bezos an $80,000 yearly salary—but $1.6 million for travel and security | Fortune Trump-backed World Liberty Financial crypto tokens reach all-time low on reports of insider loans | Fortune Iran is demanding tankers in the Strait of Hormuz pay tolls in crypto: What we know so far | Fortune First they went after medtech, then Kash Patel. Iranian hackers’ next target is likely ‘low-hanging fruit’ in water, energy, and tourism, experts say | Fortune The AI that found 27-year-old vulnerabilities no human ever caught before just forced an emergency meeting with every major Wall Street CEO | Fortune Inflation goes up by a whopping monthly rate of nearly 1%—and it’s hitting you at the grocery store and gas station | Fortune H&R Block is betting it can be more than a tax company | Fortune The real engine of innovation is trust | Fortune Huntington is powering digital growth—by opening a branch almost every 2 weeks, says CFO | Fortune How the 173-year-old glass-maker behind Edison's light bulb and iPhone screens became a Silicon Valley darling | Fortune
What is NMN: Everything you need to know from Experts | Fortune
Katie Moore · 2026-04-04 · via Fortune | FORTUNE

Longevity supplements are becoming increasingly popular, and one molecular compound gaining attention is nicotinamide mononucleotide (NMN). Naturally found in the body, NMN converts directly to nicotinamide adenine dinucleotide (NAD+), a coenzyme that contributes to energy production, metabolism, and overall cellular health, making it a key player in how our bodies function over time.

The growing interest in NMN aligns with a broader cultural shift in how people are thinking about aging. Registered Dietitian Avery Zenker points out that “longevity science isn’t only focused on increasing lifespan, but also improving healthspan.” Healthspan, in short, refers to living better as you age, not just living longer. According to Zenker, “NMN stands out for its potential to impact both lifespan and healthspan.”

So, what exactly is NMN, and why is it being promoted by so many wellness influencers? In this article, we look at how NMN works in your body, and we break down the claims around this popular wellness supplement.

What is NMN?

Naturally found in the body, NMN converts directly to NAD+, a compound essential for good health. An increase in NAD+ is associated with increased energy production and faster cellular repair.

Emerging research shows that NAD+ levels decrease greatly in middle age. According to Rachel Pojednic, PhD, Chief Science Officer at RestoreLabs and Restore Hyper Wellness, the popularity of NMN supplements is based on the idea “that by supplementing with NMN, you can increase NAD+ availability and potentially support cellular processes that are associated with healthy aging.”

How do NMN supplements work?

Pojednic explains it this way: an NAD+ boosting supplement like NMN is not like a direct infusion of NAD+ to your body. Rather, the supplements provide essential building blocks (called precursors) that help your cells make NAD+ on their own.

“NAD+ does not occur in high concentrations in the blood,” Pojednic explains, “and in fact, that would be an indicator to the immune system that something was wrong.” By using a precursor, like an NMN supplement, your body can produce NAD+ where it’s needed—inside your cells—without setting off any alarms within your immune system.

Although studies have shown that NMN supplements can increase NAD+ concentration, there are limited studies linking these increased NAD+ levels to changes in body composition or disease risk.

What experts say about NMN supplements

In 2022, the Food and Drug Administration (FDA) restricted the sale of NMN supplements because they were being investigated as pharmaceutical drugs. This decision was about regulatory classifications, not safety, but it has resulted in fewer human trials on the supplements over the past several years. In 2025, the ban on NMN supplements was lifted, and the supplement is finding its way back to the market and, potentially, to more clinical trials.

What’s clear from current studies is that NMN supplements increase NAD+ concentrations, with clinical trials showing “increases in whole blood NAD+ or related metabolites after NMN supplementation, which tells us the compound is biologically active and reaching its target,” Pojednic says. Such studies could point toward promising health outcomes, such as reduced inflammation and increased energy production.

Still, Pojednic says, “translating that into healthy aging in humans is where the evidence becomes much less clear.”

Benefits of taking NMN

While human trials on NMN supplements are limited, there is some promising research showing potential benefits, particularly insulin sensitivity, cardiovascular health, and metabolic health.

Here are some of the potential benefits of taking NMN supplements:

Increased levels of NAD+

Chronic, low-grade inflammation associated with aging (known popularly as “inflammaging”) gradually depletes NAD+ levels. NMN supplements provide a precursor that can help replenish these declining levels and support cellular health over time.

Protection against cancer and other chronic illnesses

Increased NAD+ levels can reduce inflammation throughout the body, potentially helping protect cells from DNA damage and oxidative stress, both of which are associated with cancer and neurological diseases like Alzheimer’s.

Support for metabolic health

One study found that NMN improved insulin sensitivity, a key marker of metabolic health, in the muscles of postmenopausal women with prediabetes and obesity. No data shows whether or not this finding translates to other populations.

Increased energy production

NMN supplementation resulted in increased NAD+ levels and an increased walking speed in older adults, one study showed. Additionally, participants reported better sleep quality, hinting at supportive effects on recovery and daily energy.

Improved brain health

In non-human studies, NMN supplements have been shown to improve cognitive function and reduce brain plaques associated with Alzheimer’s.

While these studies show exciting potential benefits of NMN supplements, more research is needed to show the long-term health benefits of NMN in the general population.

NMN’s potential side effects

In healthy people, a 1250 mg daily dose appears to be safe and well-tolerated for short-term use. “There’s a lack of safety data on other populations,” though, says Zenker, “like pregnant or breastfeeding women, children and adolescents, individuals with pre-existing health conditions, and those taking medications that could interfere with NAD+ and NMN processing.”

“Most human trials are relatively short, weeks to a few months, so we simply do not have robust long-term safety data,” Pojednic adds.

Anyone considering an NMN supplement, especially for long-term or high-dose use, should proceed with caution and be sure to consult with your doctor.

How to take NMN supplements

As NMN supplements have gained popularity, they’ve taken several forms, from IV infusions to capsules. Here are a few common NMN supplement forms:

  • Powder
  • Capsule
  • Sublingual tablets (dissolve under the tongue)
  • Nasal/oral sprays
  • IV infusion

Registered Dietitian Jane Leverich points out that oral NMN supplements in powder or capsule form are the most commonly studied and have been shown to safely increase NAD+ levels in appropriate doses. “Though other delivery methods may be marketed as more effective,” she says, “there isn’t enough strong evidence to support their safety or that they offer additional benefits.”

Trace levels of NMN are also found in certain vegetables and lean meats, like broccoli, avocado, and beef, but the quantities are low and not likely to greatly impact NAD+ levels. “Rather than focusing on getting NMN directly through the diet, it’s more realistic to support NAD+ production overall through a balanced diet rich in protein that provides key nutrients like niacin and tryptophan, which help produce NAD+,” Leverich says. In other words, aim to increase your intake of niacin (vitamin B3) from foods like salmon, liver, and tuna. Other sources include legumes and fortified grains.

Do NMN supplements work?

At doses of 250 to 2000 mg daily, there is strong evidence to show that NMN supplements increase NAD+ levels in the blood and tissues. NAD+ plays a critical role in cellular energy production, DNA repair, and metabolic health. Your cells need it to survive and help you stay healthy and active. Because NAD+ levels decrease as we age, NMN supplements have grown popular as a tool for supporting longevity and overall health.

While preliminary findings are promising, there is limited clinical evidence in humans to confirm that increasing NAD+ through NMN supplements consistently leads to optimal long-term health or anti-aging outcomes. More large-scale and long-term studies are needed to determine the real-world impact of NMN supplements.

“For now,” Leverich says, “focusing on proven lifestyle habits like a nutrient-rich diet, staying physically active, prioritizing sleep, and managing stress remains the most reliable approach for increasing NAD+ levels.”

FAQs

What are NMN supplements?

NMN (nicotinamide mononucleotide) supplements provide your body with a precursor to NAD+, a coenzyme essential to your body’s energy production, metabolism, and overall cellular health. While NMN supplements do not supply NAD+ directly, they do help your cells produce it internally, where it’s needed most. Because NAD+ levels naturally decline with age, NMN’s ability to boost NAD+ levels is bringing it into the spotlight for potential anti-aging benefits.

What is NMN good for?

NMN is best known for its ability to increase NAD+ levels, which play an important role in cellular energy and metabolic processes. Some early research suggests that increased NAD+ levels may support better metabolic health, physical function, and energy levels, with studies showing improvements in insulin sensitivity in postmenopausal women and walking speed in older adults. Still, more long-term human studies are needed to confirm any long-term anti-aging benefits of NMN supplements.

Is NMN safe for anyone to take?

NMN is generally safe and well-tolerated in healthy adults at doses up to 1250 mg daily for short-term use. There is limited safety data for certain groups of people, though, such as pregnant or breastfeeding women, people with pre-existing health conditions, and children. Also, because most human NMN studies have been short-term, no information about long-term safety is yet available. If you’re considering an NMN supplement, especially at a high dose or for long-term use, consult a healthcare provider first.